These findings challenge the notion that ADan and AD‐like pathology solely drive neuronal damage and dementia in individuals with FDD and indicate that the FDD mutation behaves like a hypomorphic mutation with reduced levels of functional mature BRI2 while also generating the mutant, pro‐amyloidogenic ADan peptide. This evidence concerns the gene ITM2B and dementia.